Influence of G-CSF and EPO on Associative Learning and Motor Skills

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-03-31

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the study we want to prove whether the subcutaneous application of granulocyte-stimulating factor (G-CSF) and erythropoetin (EPO) influence associative learning and/or motor skills of patients, who suffer from chronic stroke or amyotrophic lateral sclerosis. The study hypothesis is that G-CSF and EPO improve associative learning and/or motor skills.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury

NCT02018406

Neurological Diseases Ischemic Stroke Hemorrhagic Stroke +2 more

RECRUITING PHASE1/PHASE2

Novel Brain Signal Feedback Paradigm to Enhance Motor Learning After Stroke

NCT02856035

Stroke

COMPLETED NA

Motor Learning in Stroke Patients and Healthy Volunteers

NCT00021710

Stroke Healthy

COMPLETED

Epidural Electrical Stimulation for Stroke Patients - Improve Motor and Sensory Function and Alleviate Pain

NCT05981989

Stroke

RECRUITING NA

Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity

NCT00460655

Post-Stroke Spasticity Cerebrovascular Accident

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Stroke Amyotrophic Lateral Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

granulocyte - colony stimulating factor (G-CSF)

Intervention Type DRUG

erythropoetin (EPO)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of chronic stroke or amyotrophic lateral sclerosis

Exclusion Criteria

* leucocytes \> 10000/µl
* hematocrit \> 48%
* thrombocytes \< 150000/µl
* severe rheumatoid arthritis
* severe infection
* severe liver or renal failure
* severe arterial hypertension
* recurrent thromboembolic events
* severe coronary heart disease
* myocardial infarction
* malignant tumor
* leukemia
* peripheral arterial occlusion disease

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No